We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

69 hedge funds and large institutions have $614M invested in Dyne Therapeutics in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

146% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 13

44% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 9

38% more funds holding

Funds holding: 50 → 69 (+19)

12% more capital invested

Capital invested by funds: $550M → $614M (+$64.9M)

3.95% more ownership

Funds ownership: 60.52% → 64.47% (+4%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
69
Holders Change
+19
Holders Change %
+38%
% of All Funds
1.22%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
32
Increased
13
Reduced
9
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$14.5M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$12.8M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$7.16M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.67M
5
WP
Woodline Partners
California
+$4.43M

Top Sellers

1
SAM
Sectoral Asset Management
Quebec, Canada
-$9.58M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$7.04M
3
Franklin Resources
Franklin Resources
California
-$4.85M
4
FCM
Farallon Capital Management
California
-$4.04M
5
Millennium Management
Millennium Management
New York
-$3.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
51
Athanor Capital
New York
$225K +$212K +10,738 New
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$218K +$206K +10,400 New
D.E. Shaw & Co
53
D.E. Shaw & Co
New York
$216K +$203K +10,280 New
CSS
54
Cubist Systematic Strategies
Connecticut
$211K +$198K +10,031 New
UBS Group
55
UBS Group
Switzerland
$209K +$197K +9,960 New
Nisa Investment Advisors
56
Nisa Investment Advisors
Missouri
$158K +$148K +7,506 New
MIM
57
MetLife Investment Management
New Jersey
$157K +$148K +7,479 New
Wells Fargo
58
Wells Fargo
California
$155K +$146K +7,389 New
JP Morgan Chase
59
JP Morgan Chase
New York
$134K +$126K +6,380 New
MLICM
60
Metropolitan Life Insurance Company (MetLife)
New York
$110K +$103K +5,226 New
SO
61
STRS Ohio
Ohio
$73K +$69.2K +3,500 New
Bank of Montreal
62
Bank of Montreal
Ontario, Canada
$60K +$44.1K +2,229 New
FMT
63
First Mercantile Trust
Tennessee
$56K +$52.3K +2,644 New
Citigroup
64
Citigroup
New York
$56K +$52.6K +2,659 New
Legal & General Group
65
Legal & General Group
United Kingdom
$31K +$19.4K +982 +198%
AIP
66
Ameritas Investment Partners
Nebraska
$25K +$23.6K +1,192 New
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$14K +$13K +656 New
TRCT
68
Tower Research Capital (TRC)
New York
$9K +$6.45K +326 +265%
AIG
69
American International Group
New York
$174 +$164K +8,273 New
SAM
70
Sectoral Asset Management
Quebec, Canada
– -$9.58M -474,301 Closed
FCM
71
Farallon Capital Management
California
– -$4.04M -200,000 Closed
HM
72
HealthCor Management
New York
– -$2.42M -120,000 Closed
MIM
73
Monashee Investment Management
Massachusetts
– -$2.17M -107,735 Closed
ECM
74
ExodusPoint Capital Management
New York
– -$1.58M -78,448 Closed
MWNA
75
Marshall Wace North America
New York
– -$861K -42,623 Closed
1 2
3
4

DYN Hedge Fund Activity: Q4 2020 in Review

69 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q4 2020, worth a combined $614M — up 12% from $550M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new DYN positions and 13 closed out — a net gain of 19 holders — while 13 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $14.5M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $9.58M sold.

  • 69 institutional investors held Dyne Therapeutics (DYN) as of Q4 2020, up from 50 in Q3 2020.
  • Funds reported $614M of Dyne Therapeutics stock for Q4 2020, up 12% quarter-over-quarter.
  • 32 funds opened new Dyne Therapeutics positions in Q4 2020 and 13 closed out, a net change of +19 holders.
  • The largest Dyne Therapeutics buyer in Q4 2020 was BlackRock, an estimated $14.5M added.
  • The largest Dyne Therapeutics seller in Q4 2020 was Sectoral Asset Management, an estimated $9.58M sold.

Based on aggregated 13F filings for Q4 2020.